Zhou et al. [19] showed that miR-506 could enhance the sensitivity of CRC cells to oxaliplatin via inhibition of the Wnt/β-catenin signaling pathway by suppressing MDR1/P-gp expression. The gene discussed is PGP; the disease is colorectal carcinoma.